Additional Post Hoc Analysis and Clinical Data Collection
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 8 - 99 |
Updated: | 1/19/2018 |
Start Date: | July 2016 |
End Date: | December 2021 |
Contact: | Mark D Skopin, PhD |
Email: | mark@elminda.com |
Phone: | 2248880060 |
Additional Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
The purpose of this study is to collect additional Investigational cognitive tasks and
additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).
additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).
To collect additional Investigational cognitive tasks and additional clinical data for
subjects tested with ElMindA's Brain Network Activation (BNA™).
The BNA™ technology was developed and is utilized by ElMindA Ltd. The (BNA™) Analysis System
is cleared for use by qualified medical professionals for the post hoc statistical analysis
of the human electroencephalogram ("EEG"), utilizing evoked response potentials ("ERP').
subjects tested with ElMindA's Brain Network Activation (BNA™).
The BNA™ technology was developed and is utilized by ElMindA Ltd. The (BNA™) Analysis System
is cleared for use by qualified medical professionals for the post hoc statistical analysis
of the human electroencephalogram ("EEG"), utilizing evoked response potentials ("ERP').
Inclusion Criteria:
- Completed a BNA test in the past
- Able to speak, read and understand English sufficiently to understand the nature of
the study, and to allow completion of all study assessments.
- Willingness to participate
Exclusion Criteria:
- Significant Sensory deficit
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials